Per-App Summary of Results Kit Huckvale, Global eHealth Unit, Imperial College London 15 September 2015 Since the publication of our study, there has been ongoing interest in which apps performed better or worse during our assessment. Because the intention of the work was to provide a cross sectional overview of the state of apps at a particular point in time, rather than an accreditation/review of individual products, we did not include this information in our original manuscript. However, we support the principle of transparent disclosure of research data and, recognising the level of interest, a per-app summary of our findings is now available for download from: http://bit.ly/InsulinDosePerAppSummary These data were not intended to endorse - and should not be interpreted as endorsing - the use of any particular apps. The findings will inevitably change as new app versions are released; and clinical and situational factors must also be considered when judging the suitability of apps for particular patients. We welcome comments, and would be happy to provide additional information on request. Please get in touch using the corresponding author details. Competing interests I am one of the study authors.